The Safety and Effectiveness of Low-Dose Recombinant Tissue Plasminogen Activator (0.6 mg/kg) Therapy for Elderly Acute Ischemic Stroke Patients (≥ 80 Years Old) in the Pre-endovascular Era

There are still few studies of low-dose recombinant tissue plasminogen activator (rtPA) therapy (0.6 mg/kg) for acute ischemic stroke (AIS) patients ≥ 80 years old, though most strokes occur in elderly people. The safety and effectiveness of this form of thrombolysis without endovascular therapy wer...

Descripción completa

Detalles Bibliográficos
Autores principales: TAKAYANAGI, Shunsaku, OCHI, Takashi, HANAKITA, Shunya, SUZUKI, Yasutaka, MAEDA, Keiichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japan Neurosurgical Society 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4533450/
https://www.ncbi.nlm.nih.gov/pubmed/24670312
http://dx.doi.org/10.2176/nmc.oa.2013-0264

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4533450/
https://www.ncbi.nlm.nih.gov/pubmed/24670312
http://dx.doi.org/10.2176/nmc.oa.2013-0264

Ejemplares similares